163 related articles for article (PubMed ID: 27402288)
1. Toll-like receptors signaling: A complex network for NF-κB activation in B-cell lymphoid malignancies.
Ntoufa S; Vilia MG; Stamatopoulos K; Ghia P; Muzio M
Semin Cancer Biol; 2016 Aug; 39():15-25. PubMed ID: 27402288
[TBL] [Abstract][Full Text] [Related]
2. NF-κB activation in chronic lymphocytic leukemia: A point of convergence of external triggers and intrinsic lesions.
Mansouri L; Papakonstantinou N; Ntoufa S; Stamatopoulos K; Rosenquist R
Semin Cancer Biol; 2016 Aug; 39():40-8. PubMed ID: 27491692
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of iNOS expression and apoptosis resistance in B-cell chronic lymphocytic leukemia (B-CLL) cells through engagement of Toll-like receptor 7 (TLR-7) and NF-kappaB activation.
Hammadi A; Billard C; Faussat AM; Kolb JP
Nitric Oxide; 2008 Sep; 19(2):138-45. PubMed ID: 18474259
[TBL] [Abstract][Full Text] [Related]
4. Absence of Non-Canonical, Inhibitory
Cardona Gloria Y; Bernhart SH; Fillinger S; Wolz OO; Dickhöfer S; Admard J; Ossowski S; Nahnsen S; Siebert R; Weber ANR
Front Immunol; 2021; 12():616451. PubMed ID: 34163463
[TBL] [Abstract][Full Text] [Related]
5. Salvia miltiorrhiza polysaccharide activates T Lymphocytes of cancer patients through activation of TLRs mediated -MAPK and -NF-κB signaling pathways.
Chen Y; Li H; Li M; Niu S; Wang J; Shao H; Li T; Wang H
J Ethnopharmacol; 2017 Mar; 200():165-173. PubMed ID: 28232127
[TBL] [Abstract][Full Text] [Related]
6. The hepatitis B e antigen (HBeAg) targets and suppresses activation of the toll-like receptor signaling pathway.
Lang T; Lo C; Skinner N; Locarnini S; Visvanathan K; Mansell A
J Hepatol; 2011 Oct; 55(4):762-9. PubMed ID: 21334391
[TBL] [Abstract][Full Text] [Related]
7. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction.
Fitzgerald KA; Palsson-McDermott EM; Bowie AG; Jefferies CA; Mansell AS; Brady G; Brint E; Dunne A; Gray P; Harte MT; McMurray D; Smith DE; Sims JE; Bird TA; O'Neill LA
Nature; 2001 Sep; 413(6851):78-83. PubMed ID: 11544529
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor signaling pathway in chronic lymphocytic leukemia: distinct gene expression profiles of potential pathogenic significance in specific subsets of patients.
Arvaniti E; Ntoufa S; Papakonstantinou N; Touloumenidou T; Laoutaris N; Anagnostopoulos A; Lamnissou K; Caligaris-Cappio F; Stamatopoulos K; Ghia P; Muzio M; Belessi C
Haematologica; 2011 Nov; 96(11):1644-52. PubMed ID: 21750087
[TBL] [Abstract][Full Text] [Related]
9. Molecular deregulation of signaling in lymphoid tumors.
Spina V; Martuscelli L; Rossi D
Eur J Haematol; 2015 Oct; 95(4):257-69. PubMed ID: 25881749
[TBL] [Abstract][Full Text] [Related]
10. C-type lectin DC-SIGN modulates Toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-kappaB.
Gringhuis SI; den Dunnen J; Litjens M; van Het Hof B; van Kooyk Y; Geijtenbeek TB
Immunity; 2007 May; 26(5):605-16. PubMed ID: 17462920
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor stimulation in cardiomyoctes decreases contractility and initiates an NF-kappaB dependent inflammatory response.
Boyd JH; Mathur S; Wang Y; Bateman RM; Walley KR
Cardiovasc Res; 2006 Dec; 72(3):384-93. PubMed ID: 17054926
[TBL] [Abstract][Full Text] [Related]
12. Combined CpG and poly I:C stimulation of monocytes results in unique signaling activation not observed with the individual ligands.
Arsenault RJ; Kogut MH; He H
Cell Signal; 2013 Nov; 25(11):2246-54. PubMed ID: 23876795
[TBL] [Abstract][Full Text] [Related]
13. Nuclear factor-kappaB: activation and regulation during toll-like receptor signaling.
Carmody RJ; Chen YH
Cell Mol Immunol; 2007 Feb; 4(1):31-41. PubMed ID: 17349209
[TBL] [Abstract][Full Text] [Related]
14. Extracellular HSP60 induces inflammation through activating and up-regulating TLRs in cardiomyocytes.
Tian J; Guo X; Liu XM; Liu L; Weng QF; Dong SJ; Knowlton AA; Yuan WJ; Lin L
Cardiovasc Res; 2013 Jun; 98(3):391-401. PubMed ID: 23447644
[TBL] [Abstract][Full Text] [Related]
15. CD300F blocks both MyD88 and TRIF-mediated TLR signaling through activation of Src homology region 2 domain-containing phosphatase 1.
Lee SM; Kim EJ; Suk K; Lee WH
J Immunol; 2011 Jun; 186(11):6296-303. PubMed ID: 21536801
[TBL] [Abstract][Full Text] [Related]
16. Inflammation, cancer and chemoresistance: taking advantage of the toll-like receptor signaling pathway.
Chen R; Alvero AB; Silasi DA; Mor G
Am J Reprod Immunol; 2007 Feb; 57(2):93-107. PubMed ID: 17217363
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms and consequences of constitutive NF-κB activation in B-cell lymphoid malignancies.
Nagel D; Vincendeau M; Eitelhuber AC; Krappmann D
Oncogene; 2014 Dec; 33(50):5655-65. PubMed ID: 24469030
[TBL] [Abstract][Full Text] [Related]
18. Targeting NF-kappaB in hematologic malignancies.
Braun T; Carvalho G; Fabre C; Grosjean J; Fenaux P; Kroemer G
Cell Death Differ; 2006 May; 13(5):748-58. PubMed ID: 16498458
[TBL] [Abstract][Full Text] [Related]
19. Chemo-sensitizing effects of EP4 receptor-induced inactivation of nuclear factor-κB.
Gobec M; Prijatelj M; Delić J; Markovič T; Mlinarič-Raščan I
Eur J Pharmacol; 2014 Nov; 742():81-8. PubMed ID: 25218986
[TBL] [Abstract][Full Text] [Related]
20. NF-κB activation via MyD88-dependent Toll-like receptor signaling is inhibited by trichothecene mycotoxin deoxynivalenol.
Sugiyama K; Muroi M; Kinoshita M; Hamada O; Minai Y; Sugita-Konishi Y; Kamata Y; Tanamoto K
J Toxicol Sci; 2016 Apr; 41(2):273-9. PubMed ID: 26961612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
